Article
Role of XRCC1 gene polymorphisms in non-small cell lung cancer cisplatin-based chemotherapy, and their effect on clinical and pathological characteristics.
Genetics and molecular research : GMR - 23 Dec 2016
Liu H F, Liu J S, Deng J H, Wu R R
Abstract excerpt
Non-small cell lung cancer (NSCLC) is the most common cancer globally. The XRCC1 protein interacts with ligase and poly(ADP-ribose) polymerase to repair cisplatin-induced DNA damage. The authors of previous studies have reported XRCC1 Arg399Gln, Arg280His, and Arg194Trp polymorphisms and advanced NSCLC prognosis, but the results are inconclusive. We investigated the association between clinical outcome and XRCC1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
